Literature DB >> 9573672

Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.

G D'Arena1, P Musto, N Cascavilla, G Di Giorgio, S Fusilli, F Zendoli, M Carotenuto.   

Abstract

BACKGROUND AND
OBJECTIVE: One of the most important potential advantages in the use of human umbilical cord blood (HUCB) for hematopoietic reconstitution after myeloablative therapy seems to be the lower occurrence of acute graft-versus-host-disease (GvHD) in recipients after allogeneic transplantation. Since mature T cells play an important role in GvHD pathogenesis, we tried to verify whether a different immunophenotypic pattern exists between HUCB and peripheral blood (PB) T cells. DESIGN AND METHODS: An immunophenotypic study on 40 HUCB and 40 PB samples from healthy adult volunteers was performed, by means of flow cytometry using a large panel of monoclonal antibodies in double labeling.
RESULTS: The absolute lymphocyte count was greater in HUCB (5233 +/- 1808 microL) than in adult PB (1941 +/- 378 microL). Significant differences in percentage were found between cord and adult T-cells, respectively (CD3+: 59.9 +/- 12 vs 74.9 +/- 4.6%), CD3- CD16+ and/or CD56+ natural killer (NK) cells (23.8 +/- 10.1 vs 10.8 +/- 5.3%) and CD3+CD16+ and/or CD56+ cytotoxic T lymphocyte subset (0.3 +/- 0.3 vs 10.7 +/- 4.1%). There was no difference in CD4/CD8 ratio (1.7 +/- 0.5 vs 1.6 +/- 0.2%) between the two groups. In absolute terms, HUCB contained an higher number of all lymphocyte subsets, with the exception of CD3+CD16+ and/or CD56+ T lymphocyte subpopulation, CD3+CD25+ and CD3+HLADR+ activated T-cells. CD38, a marker of activation and immaturity, was present on virtually all cord T cells and on approximately half of the adult T cells. The large majority of HUCB T cells co-expressed CD45RA naive antigen (CD4+CD45RA+: 87.6 +/- 5.2%, CD8+ CD45RA+: 93.5 +/- 7.8%; CD4+CD45RO+: 12.3 +/- 5.2%; CD8+CD45RO+: 6.4 +/- 7.8%) whereas in adult PB T cells an higher number of CD45RO+ memory cells was detected (CD4+CD45RA+: 44.8 +/- 9.6%; CD8+CD45RA: 71.5% +/- 8.1%; CD4+CD45RO+: 55.2 +/- 9.6%; CD8+ CD45RO+: 28.5 +/- 8.1%). Finally, less than 14% of lymphocytes were shown to belong to B lineage in both sources, while, in absolute terms, they were more represented in HUCB with respect to adult PB. INTERPRETATION AND
CONCLUSIONS: In the present study we found significant difference between HUCB and adult PB lymphocytes in their immunophenotypic profile. In particular HUCB showed T lymphocytes that appeared to be phenotypically immature. Indeed, as a likely consequence of poor antigenic experience during pregnancy, the majority of HUCB cells were naive, expressing the RA isoform of the CD45 molecule. These findings could justify the previously reported reduced cord blood lymphocyte alloreactivity when allogeneic transplantation is performed and require further functional studies in order to confirm the impairment of HUCB immune system response to alloantigens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573672

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  55 in total

1.  Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.

Authors:  Natalie J Thornburg; Bryan Shepherd; James E Crowe
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 2.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

3.  Age-related changes in expression of CXCR4 and CCR5 on peripheral blood leukocytes from uninfected infants born to human immunodeficiency virus type 1-infected mothers.

Authors:  Sharon Shalekoff; Glenda E Gray; Caroline T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

4.  Optimized multiparametric immunophenotyping of umbilical cord blood cells by flow cytometry.

Authors:  Christina Basford; Nico Forraz; Colin McGuckin
Journal:  Nat Protoc       Date:  2010-06-24       Impact factor: 13.491

5.  Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant.

Authors:  Sami B Kanaan; Hilary S Gammill; Whitney E Harrington; Stephen C De Rosa; Philip A Stevenson; Alexandra M Forsyth; Judy Allen; Emma Cousin; Koen van Besien; Colleen S Delaney; J Lee Nelson
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

6.  Evaluation of various methods of maternal placental blood collection for immunology studies.

Authors:  Caroline Othoro; Julie M Moore; Kathleen Wannemuehler; Bernard L Nahlen; Juliana Otieno; Laurence Slutsker; Altaf A Lal; Ya Ping Shi
Journal:  Clin Vaccine Immunol       Date:  2006-05

7.  Maturation of CD4+ regulatory T lymphocytes and of cytokine secretions in infants born prematurely.

Authors:  V Dirix; F Vermeulen; F Mascart
Journal:  J Clin Immunol       Date:  2013-06-21       Impact factor: 8.317

8.  Critical Role for Monocytes/Macrophages in Rapid Progression to AIDS in Pediatric Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Chie Sugimoto; Kristen M Merino; Atsuhiko Hasegawa; Xiaolei Wang; Xavier A Alvarez; Hiroshi Wakao; Kazuyasu Mori; Woong-Ki Kim; Ronald S Veazey; Elizabeth S Didier; Marcelo J Kuroda
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 9.  Umbilical cord blood research: current and future perspectives.

Authors:  Jennifer D Newcomb; Paul R Sanberg; Stephen K Klasko; Alison E Willing
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

10.  Successful cord blood transplantation for a CHARGE syndrome with CHD7 mutation showing DiGeorge sequence including hypoparathyroidism.

Authors:  Hirosuke Inoue; Hidetoshi Takada; Takeshi Kusuda; Takako Goto; Masayuki Ochiai; Tadamune Kinjo; Jun Muneuchi; Yasushi Takahata; Naomi Takahashi; Tomohiro Morio; Kenjiro Kosaki; Toshiro Hara
Journal:  Eur J Pediatr       Date:  2010-01-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.